Clinical Trial Update: Phase 2 Study - Erdosteine in Patients With CB/COPD [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating erdosteine in chronic bronchitis and chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Erdosteine (erdosteine)

Snippet

Sponsor: Adams Respiratory Therapeutics | Conditions: Chronic Bronchitis, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED